Skip to main content

Advertisement

Log in

Persistent eosinophilia in rheumatoid arthritis: a prospective observational study

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Eosinophilia is an uncommon manifestation in Rheumatoid arthritis (RA), and there is a paucity of data regarding the relationship of eosinophilia with disease-related factors. We prospectively evaluated the clinical and disease-specific characteristics of RA patients with eosinophilia. Consecutive patients with RA with an absolute eosinophil count ≥ 500/mm3 without an apparent cause for eosinophilia, were investigated for parasitic infestation. Patients with a definite parasitic infestation received targeted therapy, and the rest were treated with albendazole empirically. The RA disease-specific characteristics of the patients with persistent eosinophilia were compared with the patients without eosinophilia. Of the 160 patients with eosinophilia, 30 patients (19%) had allergic diseases, six patients had bronchiectasis, and one patient had hypereosinophilia of undetermined significance. Intestinal helminthiasis was found in 34 patients (21%). Eosinophilia was unexplained in 89 patients (56%) and it resolved after empirical albendazole therapy in about two-thirds (58 patients). Thirty-one patients had persistent eosinophilia. Nonsteroidal anti-inflammatory drug and disease-modifying antirheumatic drug modification did not show any effect on eosinophilia. The disease-related characteristics were similar between patients with persistent eosinophilia and those without eosinophilia. Eosinophilia is due to secondary causes in the majority of RA patients, and the most common cause in our setting is an intestinal helminthic infection. Persistent eosinophilia in our cohort of RA did not indicate a more severe disease phenotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ACPA:

Anti-citrullinated protein antibodies

AEC:

Absolute eosinophil count

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

DAS28:

Disease activity score in 28 joints

DMARDs:

Disease-modifying antirheumatic drugs

DRESS:

Drug rash with eosinophilia and systemic symptoms

ELISA:

Enzyme-linked immunosorbent assay

ESPOIR:

Etude et Suivi des POlyarthrites Indifférenciées Récentes

ESR:

Erythrocyte sedimentation rate

FIP1L1-PDGFRA (F/P):

Fip1-like 1-platelet-derived growth factor receptor alpha fusion gene

HCQ:

Hydroxychloroquine

HEus:

Hypereosinophilia of undetermined significance

IHAQ:

Indian version of the Health Assessment Questionnaire

ILD:

Interstitial lung disease

LEF:

Leflunomide

MTX:

Methotrexate

NSAIDs:

Nonsteroidal anti-inflammatory drugs

PDGFRB:

Platelet-derived growth factor receptor beta

RA:

Rheumatoid arthritis

RF:

Rheumatoid factor

SJ:

Swollen joint

SSZ:

Sulfasalazine

TJ:

Tender joint

VAS:

Visual analog scale

References

  1. Tamaki H, Chatterjee S, Langford CA (2015) Eosinophilia in rheumatologic/vascular disorders. Immunol Allergy Clin N Am 35:453–476. https://doi.org/10.1016/j.iac.2015.05.001

    Article  Google Scholar 

  2. Chiardola F, Schneeberger EE, Citera G et al (2008) Prevalence and clinical significance of eosinophilia in patients with rheumatoid arthritis in Argentina. J Clin Rheumatol 14:211–213. https://doi.org/10.1097/RHU.0b013e31817738ce

    Article  PubMed  Google Scholar 

  3. Guellec D, Milin M, Cornec D et al (2015) Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort. RMD Open 1:e000070. https://doi.org/10.1136/rmdopen-2015-000070

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sofi F, Parrey A, Ahmad M (2016) Eosinophilia in rheumatoid arthritis patients and its relation to disease activity: a single center experience from Kashmir, India. Egypt Rheumatol. https://doi.org/10.1016/j.ejr.2016.10.002

    Article  Google Scholar 

  5. Kang G, Mathew MS, Rajan DP et al (1998) Prevalence of intestinal parasites in rural Southern Indians. Trop Med Int Heal 3:70–75

    Article  CAS  Google Scholar 

  6. Kaliappan SP, George S, Francis MR et al (2013) Prevalence and clustering of soil-transmitted helminth infections in a tribal area in southern India. Trop Med Int Heal 18:1452–1462. https://doi.org/10.1111/tmi.12205

    Article  Google Scholar 

  7. Dhanabal J, Selvadoss PP, Muthuswamy K (2014) Comparative study of the prevalence of intestinal parasites in low socioeconomic areas from South chennai, India. J Parasitol Res 2014:630968. https://doi.org/10.1155/2014/630968

    Article  PubMed  PubMed Central  Google Scholar 

  8. Doran MF, Crowson CS, Pond GR et al (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287–2293. https://doi.org/10.1002/art.10524

    Article  Google Scholar 

  9. Doran MF, Crowson CS, Pond GR et al (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46:2294–2300. https://doi.org/10.1002/art.10529

    Article  PubMed  Google Scholar 

  10. Greenberg JD, Reed G, Kremer JM et al (2010) Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis 69:380–386. https://doi.org/10.1136/ard.2008.089276

    Article  CAS  PubMed  Google Scholar 

  11. Savolainen HA, Leirisalo-Repo M (2001) Eosinophilia as a side-effect of methotrexate in patients with chronic arthritis. Clin Rheumatol 20:432–434

    Article  CAS  PubMed  Google Scholar 

  12. Michel F, Navellou J-C, Ferraud D et al (2005) DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Jt Bone Spine 72:82–85. https://doi.org/10.1016/j.jbspin.2004.06.002

    Article  Google Scholar 

  13. Malisiewicz B, Murer C, Pachlopnik Schmid J et al (2011) Eosinophilia during psoriasis treatment with TNF antagonists. Dermatology 223:311–315. https://doi.org/10.1159/000334805

    Article  PubMed  Google Scholar 

  14. Pinto B, Dhir V, Krishnan S, Nada R (2013) Leflunomide-induced DRESS syndrome with renal involvement and vasculitis. Clin Rheumatol 32:689–693. https://doi.org/10.1007/s10067-012-2152-8

    Article  PubMed  Google Scholar 

  15. Morrisroe K, Wong M (2015) Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis. Rheumatol 54:2113–2114. https://doi.org/10.1093/rheumatology/kev275

    Article  Google Scholar 

  16. Winchester RJ, Koffler D, Litwin SD, Kunkel HG (1971) Observations on the eosinophilia of certain patients with rheumatoid arthritis. Arthritis Rheum 14:650–665

    Article  CAS  PubMed  Google Scholar 

  17. Panush RS, Franco AE, Schur PH (1971) Rheumatoid arthritis associated with eosinophilia. Ann Intern Med 75:199–205

    Article  CAS  PubMed  Google Scholar 

  18. Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584

    Article  Google Scholar 

  19. Kumar A, Malaviya AN, Pandhi A, Singh R (2002) Validation of an Indian version of the Health Assessment Questionnaire in patients with rheumatoid arthritis. Rheumatology 41:1457–1459

    Article  CAS  PubMed  Google Scholar 

  20. Yogendra V, An R, Shariff S (2011) Blood and tissue eosinophilia: a study at the MVJ Medical College and Research Hospital with Review of Literature. RGUHS J Med Sci 1:4–13

    Google Scholar 

  21. Bansal R, Kaur A, Suri AK et al (2017) Incidence of eosinophilia in rural population in North India: a study at Tertiary Care Hospital. Ann Pathol Lab Med 4:0–4. https://doi.org/10.21276/apalm.2017.1044

    Article  CAS  Google Scholar 

  22. Chammartin F, Scholte RGC, Guimarães LH et al (2013) Soil-transmitted helminth infection in South America: a systematic review and geostatistical meta-analysis. Lancet Infect Dis 13:507–518. https://doi.org/10.1016/S1473-3099(13)70071-9

    Article  PubMed  Google Scholar 

  23. Karsh J, Chen Y, Lin M, Dales R (2005) The association between allergy and rheumatoid arthritis in the Canadian population. Eur J Epidemiol 20:783–787. https://doi.org/10.1007/s10654-005-0704-9

    Article  PubMed  Google Scholar 

  24. Dougados M, Soubrier M, Antunez A et al (2013) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73:62–68. https://doi.org/10.1136/annrheumdis-2013-204223

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lai NS, Tsai TY, Koo M, Lu MC (2015) Association of rheumatoid arthritis with allergic diseases: a nationwide population-based cohort study. Allergy Asthma Proc 36:99–103. https://doi.org/10.2500/aap.2015.36.3871

    Article  PubMed  Google Scholar 

  26. Boissier MC, Semerano L, Challal S et al (2012) Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 39:222–228. https://doi.org/10.1016/j.jaut.2012.05.021

    Article  CAS  PubMed  Google Scholar 

  27. Mishra A, Yao X, Levine SJ (2013) From bedside to bench to clinic trials: identifying new treatments for severe asthma. Dis Model Mech 6:877–888. https://doi.org/10.1242/dmm.012070

    Article  PubMed  PubMed Central  Google Scholar 

  28. Simpson CR, Anderson WJA, Helms PJ et al (2002) Coincidence of immune-mediated diseases driven by TH1 and TH2 subsets suggests a common aetiology. A population-based study using computerized General Practice data. Clin Exp Allergy 32:37–42. https://doi.org/10.1046/j.0022-0477.2001.01250.x

    Article  CAS  PubMed  Google Scholar 

  29. Moore TA, Nutman TB (1998) Eosinophilia in the returning traveler. Infect Dis Clin N Am 12:503–521

    Article  CAS  Google Scholar 

  30. Curtis C, Ogbogu PU (2015) Evaluation and differential diagnosis of persistent marked eosinophilia. Immunol Allergy Clin N Am 35:387–402. https://doi.org/10.1016/j.iac.2015.04.001

    Article  Google Scholar 

  31. Roufosse F, Weller PF (2010) Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 126:39–44. https://doi.org/10.1016/j.jaci.2010.04.011

    Article  PubMed  PubMed Central  Google Scholar 

  32. Smolen JS (2016) Treat-to-target as an approach in inflammatory arthritis. Curr Opin Rheumatol 28:297–302. https://doi.org/10.1097/BOR.0000000000000284

    Article  CAS  PubMed  Google Scholar 

  33. Misra DP, Sharma A, Agarwal V (2018) Rheumatology science and practice in India. Rheumatol Int 38:1587–1600. https://doi.org/10.1007/s00296-018-4111-4

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Nonika Rajkumari, Assistant Professor, Department of Microbiology, JIPMER, for her contributions in parasitic work up.

Funding

The research was funded by an intramural research grant, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. (Grant no.: JIP/Res/Intra-DM-M.Ch/01/2015-16 and JIP/Res/Intra-DM, M.Ch/phas1/grant2/01/2016-17).

Author information

Authors and Affiliations

Authors

Contributions

(1) The conception and design of the study—DE, SCP, RK, and VSN. Acquisition of data—DE, SCP, AJ, and DPM. Analysis and interpretation of data—DE, SCP, AJ, and DPM. (2) Drafting the article—DE, AJ, and DPM. Revising it critically for important intellectual content—SCP, RK, and VSN. (3) Final approval of the version to be submitted—DE, SCP, AJ, DPM, RK, and VSN. (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved—DE, SCP, AJ, DPM, RK, and VSN.

Corresponding author

Correspondence to Vir Singh Negi.

Ethics declarations

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approved by the Institute Ethics Committee of Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India, held on 11th December 2014 (JIP/IEC/2014/10/480).

Conflict of interest

Dantis Emmanuel declares that he has no conflict of interest. Subhash Chandra Parija declares that he has no conflict of interest. Ankit Jain declares that he has no conflict of interest. Durga Prasanna Misra declares that he has no conflict of interest. Rakhee Kar declares that she has no conflict of interest. Vir Singh Negi declares that he has no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Emmanuel, D., Parija, S.C., Jain, A. et al. Persistent eosinophilia in rheumatoid arthritis: a prospective observational study. Rheumatol Int 39, 245–253 (2019). https://doi.org/10.1007/s00296-018-4191-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-018-4191-1

Keywords

Navigation